Exchange: OTC·Updated 01:39 PM EDT

About

Lipella Pharmaceuticals, Inc. develops and commercializes lipid-based therapies for common bladder syndromes. It offers LP-08 which consists of Sphingomyelin Phospholipid bilayers separated by aqueous compartments, LP-09, a liposomal formulation of Botulinum toxin, and LP-10, a proprietary liposomal formulation of Tacrolimus, a potent immunosuppressant and anti-inflammatory agent. The company was founded by Jonathan Kaufman and Michael Chancellor on February 15, 2005 and is headquartered in Pittsburgh, PA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Lipella Pharmaceuticals Inc?
What is the 52-week high for Lipella Pharmaceuticals Inc?
What is the 52-week low for Lipella Pharmaceuticals Inc?
What is Lipella Pharmaceuticals Inc stock price today?
What was Lipella Pharmaceuticals Inc stock price yesterday?
What is the Price-to-Book ratio of Lipella Pharmaceuticals Inc?
What is the 50-day moving average of Lipella Pharmaceuticals Inc?

Advertisement|Remove ads.